Yesterday I had the pleasure to delivery two research capacity building workshop sessions in Dhaka with staff at CIPRB (Centre for Injury Prevention and Research, Bangladesh). I was in Bangladesh as part of our Sonamoni project, this interdisciplinary project is jointly coordinated by Bournemouth University and CIPRB, in also includes the University of the West of England, Bristol, the University of Southampton, Design Without Borders (DWB) in Uganda, and the Royal National Lifeboat Institution (RNLI). We are working to reduce drownings among newly-mobile children, generally those under two years old. This £1.6m project has been made possible by a grant from the National Institute for Health and Care Research (NIHR) through its Research and Innovation for Global Health Transformation programme.
Two sessions covered qualitative research approaches in the morning and academic writing and publishing in the afternoon. The sessions were attended by staff involved in the Sonamoni project but we made it open to other CIPRB staff and in total 18 people attended. BU’s contributions to capacity-building initiatives aim to develop our collaborators’s research staff’s skills and increase their confidence in conducting qualitative research as well as publishing it.
Professor Edwin van Teijlingen

Research capacity building
Dedicated to drowning prevention in Bangladesh
Applying FUSION in Bangladesh
Sonamoni collaborator recognised for services rendered to water safety










BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease